wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39114552-0FF05606-F0DE-40B1-A046-0A03606133F2
Q39114552-0FF05606-F0DE-40B1-A046-0A03606133F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39114552-0FF05606-F0DE-40B1-A046-0A03606133F2
Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line
P2860
Q39114552-0FF05606-F0DE-40B1-A046-0A03606133F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39114552-0FF05606-F0DE-40B1-A046-0A03606133F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82cde0d9a61ab70028b86997a17813785f4bac22
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.